Find out more about the medical technologies advisory committee members by reading their biographies.
Professor Shaheen Hamdy
Interim vice chair
Shaheen is a professor in medicine (neurogastroenterology) within the University of Manchester, Centre Lead for GI Sciences, Institute of Inflammation and Repair and director of the Neuroscience Research Institute. He holds a clinical academic contract, delivering clinical care at Salford Royal Hospital NHS Trust for 50% of his contracted time. He is also lead academic clinician for the NIHR academic training programme in gastroenterology at the University of Manchester. He sat on the HTA EDaPT panel from 2008 to 2011 and is chair of the Neurogastroenterology and Motility Committee Section of the British Society of Gastroenterology.
Dr Katherine Boylan
Dr Katherine Boylan is head of innovation for Manchester University NHS Foundation Trust (MFT), a position she has held since April 2020. This role involves overseeing innovation activities within MFT, part of the wider research and innovation function.
The innovation team supports: intellectual property and commercialisation management; adoption of novel technologies within the Trust; strategic partnerships (with commercial organisations and other leading clinical/academic centres); a portfolio of strategic programmes (including the Diagnostic and Technology Accelerator and clinical data science unit) and the interaction with the co-located companies across the Citylabs innovation district.
Prior to this position, Katherine worked in the University of Manchester for a number of years, most recently as operations director for the Medical Research Council funded Molecular Pathology Node, and the Trust-funded Diagnostics and Technology Accelerator. Katherine’s academic background is cancer genetics (PhD, University of Dundee) and molecular biology (BSc, University of Sheffield).
Dr Stacey Chang-Douglass
Stacey is the founding director of Pro Bono Health Economist Network, a charitable organisation aiming to organise volunteers to provide pro bono research and education support to other health charities, particularly those with limited funding or resources.
Stacey is also a director in the Health Economics Analysis team at Lumanity, where she is responsible for providing strategic and technical insights across client projects.
After completing her PhD at the University of York, Stacey has been working as a health economist for over a decade, specialising in economic modelling and health technology assessment across an extensive range of therapeutic areas. She has previously worked for NICE, where she supported national guideline development.
Dr Donna Cowan
Donna is a clinical scientist who has spent most of her career working the field of assistive technology. As a research assistant in the medical engineering department of Dulwich Hospital, London she gained a PhD in biomedical engineering from King's College London. She held joint academic and clinical posts in the medical engineering and physics department of King's College Hospital. During this time as well as working in clinical services she took part in research on assistive technology and its provision. She was co-ordinator and taught on academic courses in rehabilitation engineering and jointly developed the MSc in assistive technology at King's College London.
She moved to Sussex Community NHS Foundation Trust and as a consultant clinical scientist she was head of a rehabilitation engineering service which provided a range of assistive technologies. In 2015 the department expanded to include a regional NHS communication aid service. She also became lead scientist for the Trust.
Donna is now the research and innovation director for Sussex Community NHS Foundation Trust. She remains involved in the education and training of clinical scientists in the field of rehabilitation engineering. She is also an expert witness providing reports on assistive technology. She joined MTAC in 2021.
Julian works at Intuitive. He's the director for Global Access, Value and Economics for UK, Ireland and Medtech EU. Intuitive is a patient-focused company which manufactures the da Vinci surgical system and the ion endoluminal system.
Since joining Intuitive in 2014, Julian has represented the medical device industry in a range of roles. He's been an industry representative on NHS Digital's national casemix office advisory board and also Vice Chair of the market access and economic policies committee at Medtech Europe.
After leaving the Royal Air Force in 2001, Julian worked for several medical device companies including Olympus, Smith & Nephew Orthopaedics and American Medical Systems.
Julian has gained a broad range of experience across a number of healthcare specialties including: gastroenterology; urology; ear, nose and throat; reconstructive orthopaedics; colorectal surgery; general surgery; gynaecology surgery; head and neck surgery and thoracic surgery.
Julian has held regional and national management roles in commercial areas like sales and business development, before focussing more on market access and government affairs roles: roles he has undertaken with both national and international responsibility.
Julian has a BA (Hons) degree in philosophy and music and an MA in musicology, both from the University of Southampton. In addition, Julian has a postgraduate certificate in health economics from the University of Aberdeen.
Dr Teik Goh
Teik is currently a GP partner at The Garth Surgery in Guisborough, a market town on the edge of North Yorkshire. Until recently, he worked as GP with special interest in older people in County Durham, and was the inaugural medical director then CEO/MD of ELM Alliance Ltd, the South Tees GP Federation of 43 general practices.
In his previous roles, Teik led the setting up of research network of 15 practices, extended hours and out-of-hour service as well as an innovative care home enhanced support service. In his current roles, Teik is the GP lead for the community prehabilitation project - one stop preoperative programme to improve patient fitness prior to surgery.
Teik completed MSc in Health Management at Imperial College London Business School, did health economics research at the University of Aberdeen and health services research at Newcastle University, before completing his GP training in the North East. He maintains interest in primary care research and implementation in general practice.
Professor Neil Hawkins
Neil is a professor of health technology assessment (HTA) at the University of Glasgow, Scotland. He is deputy director of the National Institute of Health Research (NIHR) funded Complex Reviews Support Unit (CRSU). His research interests include methods development for evidence synthesis and decision-analytic modelling and the use of “development focussed” HTA to support decision-making regarding the development of, and investment in, nascent healthcare technologies.
He holds postgraduate degrees in pharmacology, health economics and applied statistics and an MBA. He has worked in the pharma, academic, and consultancy sectors in roles spanning basic pharmacological research, clinical development, epidemiology, and health technology assessment
Stephen is licensed as an Anglican priest within the Diocese of Lichfield and a retired senior prison governor.
Whilst a prison governor he served in several prisons, including an open prison, a training prison, a high-security prison and a juvenile establishment. He was at one time responsible for managing the contracts for all prisoner movement in England and Wales. He retired after almost 30 years service following the suicide of his only son in 2009. He then spent 9 years as chairman of the charity PAPYRUS Prevention of Young Suicide, retiring in June 2019. During his time with the prison service he obtained an MBA from the Open University and an MSt from Cambridge University to go with his Diploma in Theology from Cardiff University.
He has been a lay member on 2 guideline committees; the mental healthcare of those in the criminal justice system and suicide prevention in the community and custody settings. He also reviews research proposals for the National Institute for Health Research.
He is a director of a CIC called 'Making Families Count'. They hold workshops to encourage NHS Trust senior managers to engage more with families in the investigation of suicides, homicides and the deaths of those with autism or learning difficulties, and to better engage with families in the provision of treatment and care.
Professor Cynthia Iglesias
Cynthia is senior health economist/health services researcher at the University of York. She has a first degree in Actuary from the National Autonomous University of Mexico, a MSc in Health Economics and a PhD in Health Services Research, both from the University of York. Cynthia is based at the Department of Health Sciences, and has had honorary appointments with the Hull and York Medical School and the Centre for Health Economics, where she is now an internal affiliate.
Cynthia's main areas of interest are economic evaluation of healthcare technologies; its contribution to healthcare policy decision making and Bayesian Sandy Newbystatistical methods for economic evaluation. In 2008, she started a personal fellowship awarded by the Medical Research Council to look at the potential contribution of Bayesian methods for evidence synthesis to the evaluation of therapeutic medical devices.
Professor Mohammad Ilyas
Mohammad is professor of aathology at Nottingham University and honorary consultant in pathology at Nottingham University Hospitals NHS Trust. His research interests are focused mainly on the genetic basis of cancer and inflammatory diseases of the gastrointestinal tract. As well as basic cell and molecular biology, he has research interests in the development of molecular diagnostics and has developed protocols for High Resolution Melting analysis (following PCR) to facilitate mutation detection.
Mohammad is on the editorial board of several journals and a founding member of the newly formed Association of Clinical Pathologists Molecular Pathology and Diagnostics group. He has previously worked with NICE on the Colorectal Cancer Guidelines Development Group and the Topic Experts Group used to develop standards from the guidelines. He was a member of the former NICE Topic Selection Consideration panel and he has also provided consultation to NICE on behalf of the Royal College of Pathologists on technology appraisals.
Michael is a health economics and commissioning manager at Medtronic, a global medical technology company. He supports the company's market access strategies by leading on health economic and reimbursement activities of innovative medical devices that alleviate pain, restore health, and extend life.
Before joining Medtronic, Michael worked in the NHS as a pharmacist and later as a medicine optimisation pharmacist in a clinical commissioning group (CCG) with a special interest in geriatric and palliative care medicine. During his time at the CCG, he worked closely with clinicians, healthcare providers, and other stakeholders to bring about transformational change that improved patient quality of care and delivered cost savings to the NHS. Michael also undertook a secondment within the Department of Health and Social Care where he supported the Medicines and Pharmacy Directorate in assessing and mitigating risks to the supply of medicines in the UK due to shortages, regulatory concerns, and Brexit.
Michael holds a Master's of Science (MSc) in Health Policy from Imperial College London. He also has a Master's of Pharmacy (MPharm) and a postgraduate certificate in Independent Prescribing, both from the University of Kent. Michael remains a registered pharmacist on the General Pharmaceutical Council and a member of the Royal Pharmaceutical Society.
Emily was a registered nurse and obtained a BA (Honours) degree in Psychology through the Open University. After leaving the NHS, Emily set up an education consultancy service that ran for 14 years.
As a non-executive director of a primary care trust, Emily involved users, carers, and community organisations in developing quality monitoring and evaluation work. In 2013, while Emily was a lay member on the NICE guideline development group for chronic hepatitis B, she initiated a series of chronic hepatitis B health education activities in Manchester in the Chinese community. The work culminated in some local individuals testing positive, and receiving treatment for this asymptomatic but potentially lethal disease.
Over the last 16 years or so, as a result of serious health problems, Emily has undergone various investigative procedures and this has brought her into close contact with advanced medical technologies. Emily hopes that her understanding and experience as a patient can add value to the discussions and evaluation of potential innovative medical technologies competing for NHS resources.
Dr Avril McCarthy
Avril is a lead clinical scientist within Clinical Engineering at Sheffield Teaching Hospitals NHS Foundation Trust. She leads its successful medical device innovation team, in which device risk management and regulatory compliance are a significant part of her role.
She began her NHS career as a biomedical scientist in haematology before furthering her interest in biomechanics and human factors. Avril was awarded a PhD in 2001 from the Faculty of Engineering at the University of Sheffield for developing and evaluating minimal access orthopaedic 'virtual environments' for surgical training. This was followed by several years of EU-funded collaborative research into orthopaedic soft tissue implants involving a number of major medical device, engineering and IT companies.
A founding member of the National Institute for Health Research (NIHR) Devices for Dignity (D4D) HTC since 2008, she has been its MedTech lead, supporting a portfolio of new technologies from incontinence products, to assistive, rehabilitative and renal technologies. She was awarded an Honorary Senior Research Fellowship in 2014 by the School of Health and Related Research (ScHARR) at the University of Sheffield and has been a lead or co-investigator on several NIHR device studies.
Professor Karen McCutcheon
Karen is a registered nurse and the director of education at Queen's University Belfast, School of Nursing and Midwifery. As director of education she has responsibility for the coordination, development, and quality assurance of programmes in relation to the disciplines of nursing and midwifery within the School.
She has published widely in the field of healthcare and nurse education and is a clinical section editor for BMJ on Examination. She served as a member of the interventional procedures advisory committee (2006 to 2016) and has participated in the development of several National Patient Safety guidelines in the UK.
Dr Duncan McPherson
Duncan is clinical director of medical devices and lead of the devices clinical team at the Medicines and Healthcare products Regulatory Agency. He is a fellow of the Royal College of Anaesthetists. He was a consultant anaesthetist at Queen Alexandra Hospital, Portsmouth. He worked for the National Patient Safety Agency as a clinical adviser. Devices Division at MHRA is the national competent authority for regulating medical devices in the UK.
Dr Naomi McVey
Naomi is the regional head of allied health professions for Health Education England (HEE). She is responsible for strategic leadership and operational support to ensure employers and Integrated Care Systems develop allied health profession (AHP) workforce supply, training, and education for service delivery and transformation across the North West. She is the national lead for HEE's AHP support workforce programme and co-chair of the North West AHP Supply and Transformation Board.
In previous roles, Naomi led the national AHP strategy implementation programme as head of programmes for the chief AHP officer at NHS England. She was a NICE fellow from 2017 to 2020 and has also worked for NICE's implementation programme. As a chartered physiotherapist, she was a member of council for the Chartered for Society of Physiotherapy from 2013 to 2015 and has held a range of clinical, management and leadership roles in the NHS.
Dr Huseyin Naci
Huseyin is an associate professor in the Department of Health Policy at the London School of Economics (LSE). He conducts research and teaches on health care policy and practice in Europe and the US. Huseyin serves as director of LSE's executive MSc programme in health economics, outcomes and management in cardiovascular sciences. He is also one of the deputy directors of the department's PhD programme.
Huseyin's research to date has evaluated the quality and quantity of the evidence base underpinning the approval, adoption, reimbursement, and use of health technologies in Europe and the US. His research has appeared in leading medical and health policy journals, including JAMA, The Lancet, The BMJ, Health Affairs, and The Milbank Quarterly.
Huseyin has a PhD from the Department of Social Policy at the LSE and a Master's in health sciences from the Johns Hopkins Bloomberg School of Public Health. He was previously a Fellow in pharmaceutical policy research (2012-13) and a Pyle Fellow in population medicine (2013-14) at the Harvard Medical School. In 2018-19, he was the recipient of the UK Harkness Fellowship in health care policy and practice, based at the Harvard Kennedy school of government.
Abdullah is a senior research fellow in systematic reviewing at the School of Health and Related Research (ScHARR) within the University of Sheffield. He is the director of ScHARR-TAG Reviews, an academic group which is involved in the production of evidence reports to support health policy decision making by NICE and other national bodies.
Abdullah has undertaken research on the clinical effectiveness of healthcare technologies for the National Institute for Health Research (NIHR) Health Technology Assessment Programme for over 15 years and has been involved with the NICE Decision Support Unit.
His research interests include the application and development of systematic review methods. In particular, the review and synthesis of diagnostic and prognostic evaluations, rapid reviews, review techniques for individual patient data and mixed treatment comparisons.
Dr David Partridge
David is a consultant medical microbiologist and infection control doctor at Sheffield Teaching Hospital NHS Foundation Trust. He is research lead for the Directorate of Laboratory Medicine at the Trust and sits on the management committee of the Florey Institute for Host-Pathogen Interaction at the University of Sheffield. His clinical interests lie in medical mycology, infections of the immunocompromised host and molecular bacteriology.
He has served as a council member for the British Infection Association since 2009 (as trainee member, membership secretary and finally communications secretary) and also sat on the grants committee of the Healthcare Infection Society from 2015 to 2018.
Dr Jai Patel
Jai is a consultant in vascular and interventional radiology at Leeds Teaching Hospitals NHS Trust (LTHT), appointed in 1999. Together with his colleagues, he provides one of the largest and most comprehensive adult and paediatric vascular interventional radiology services within the UK.
Jai's main areas of clinical interest are in trans-arterial therapies for the treatment of liver tumours, radiological management of portal hypertension and treatment of vascular malformations. He was previously lead clinician for vascular radiology at LTHT for 5 years and is currently deputy training programme director for the West Yorkshire Radiology Training Scheme.
Jai has previously undertaken national committee work as Education Committee Chair and, more recently, secretary of the British Society of Interventional Radiology (BSIR). During his time as BSIR secretary, he provided stakeholder comments on a range of relevant NICE draft interventional procedures guidance and technology appraisals.
Professor Kazem Rahimi
Kazem Rahimi is a professor of cardiovascular medicine and population health at the University of Oxford and a consultant cardiologist at the Oxford University Hospitals NHS Trust. His research interests include hypertension, heart failure, multimorbidity and cardiovascular risk management, using a variety of methodologies such as individual-patient meta-analysis, large-scale decentralised clinical trials, and digital health technologies.
Kazem leads the Deep Medicine programme at the Nuffield Department of Women's and Reproductive Health, with a major interest in the application of machine learning approaches to electronic health records. He also leads the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC), which is an international collaboration of all the major trials of blood pressure lowering drugs. He is the director of the Martin School Programme on Informal Cities and a co-investigator of the PEAK-Urban programme.
Professor Carl Roobottom
Professor Mark A Tooley FREng
Professor Roger Whittaker
Roger is Professor of Clinical Neurophysiology in the Translational and Clinical Research Institute, Newcastle University, and honorary consultant in the Department of Clinical Neurophysiology in the Royal Victoria Infirmary, Newcastle upon Tyne. His clinical and research focus is on developing and testing novel diagnostic techniques for patients with neurological diseases.
Alun is a consultant in transplant surgery and paediatric and adolescent urology at Nottingham University Hospitals. He is co-lead for paediatric transplantation and also for the living donor kidney transplant programme there. Transition and long-term care of congenital problems are further special interests.
He has been a member of the NICE guideline development groups for lower urinary tract dysfunction in neurological disease and for transition from paediatric to adult care, and was also a member of the committee developing quality standards for transition. He was a NICE fellow from 2013-16.
Find out when MTAC meetings are held and register to attend.